Gastroenterology
Understanding the complex interactions between exercise, diet and gut health can help to develop approaches to influence the gut microbiota, boost immunity and prevent or manage gastrointestinal diseases.
Phages could be used as a drug delivery system for conditions such as inflammation and obesity.
L-ornithine can be an additional therapy to boost the efficacy of ustekinumab in people with Crohn’s disease.
Reproducible biomarkers produced by several bacteria show potential as a non-invasive tool for IBD diagnosis, discriminating ulcerative colitis and Crohn’s disease patients from healthy individuals.
Maitrayee Chatterjee, Ph.D., Project Manager and Senior Scientist at InnoGI Technologies, discusses their innovative and non-invasive platform to mimic both the upper and lower gastrointestinal tract, offering precise and standardized…
Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, are long-term conditions involving gut inflammation caused by an excessive immune response. Now, a study done in mice found…
The findings of a recent study suggest a potential role of gut microbiota and microbial metabolites in the link between sugar-sweetened beverages intake and diabetes risk.
Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.
By suggesting that BA–MCYs can regulate the production of bile acids, the findings of a recent study offer insights for treating metabolic conditions such as diabetes.
A comprehensive look at the gut microbiome’s structure, functions, and strategies for sustaining its health.
